James Shaw
Neuren Pharmaceuticals
4
0
4
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jasmine Williams
Linear Clinical Research
Shared therapeutic areas:
Worked with same sponsors:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Senior Manager
Takeda
Shared therapeutic areas:
Lorenzo Berra, MD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers
All 4 trials loaded